ddn Online

The Blog of Drug Discovery News

Social butterflies

Corporations are sometimes a bit slow to pick up on technological trends, particularly when it comes to information technology. They might be somewhat behind the curve on their IT systems, and it is not uncommon for them to be really behind when it comes to an online presence. Even though so many have websites, many companies often don’t put much thought into how those site can help them and help clients, customers, partners and investors (or media, for that matter).

I’d say most of the Big Pharma and even mid-sized companies I’ve run across pretty much “get it” in terms of websites (and many smaller companies, too, though I’m shocked to find every few months a young biotech that seeks media and investor attention yet fails to have at least a rudimentary website). Well, aside from photos archives. As a member of the media, I urge more pharmas and biotechs to take good headshots, facility shots and candid shots of employees (lab workers, for example) and have them easily downloadable online in high-resolution formats. I’ll never understand why so many huge companies fail to offer that.

But I digress.

What I wanted to get at was the social media options, an area in which so many companies just miss the boat entirely, both inside and outside of pharma. With Twitter, Facebook and LinkedIn, just to name three biggies, there is no excuse for a company not to at least try to make good use of at least one, and ideally more than one. To not use social media in some way seems a sure way to show that you are behind the times. Blogs, too, are an important area to consider, either separate from or integrated into the company website.

Not everyone will use social media to the best of their potential, but then again, they don’t need to get it perfect. Not everyone nails it with marketing/advertising, employee communications, project management or public relations, either. We can’t all be good at everything.

But every company should be somewhere in terms of social media, and in that vein, I wanted to share a roundup with you of some “top 10” efforts by pharmas in the realm of social media posted on slideshare.net. It shows some notable example of what has been done by Johnson & Johnson, Glaxo-Smith-Kline, Bayer, sanofi-aventis, Novartis, AstraZeneca, Bristol-Myers Squibb, Roche, Pfizer  and Boehringer Ingelheim.

Sure, the original post was put up two years ago, but it still serves as a good example of what pharmas can do with social media, when they put their minds (and sometimes hearts) into the effort:

Click here to see the slideshow.


November 15, 2010 - Posted by | Corporate | , , , , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: